Equities researchers at StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the medical device company’s stock. NeuroMetrix Trading Down 4.0 % NURO opened at $3.82 on Monday. NeuroMetrix has a 1-year low of $2.70 and a […]